Ezetimibe

Overview

Ezetimibe is used to reduce the amount of cholesterol and related sterols absorbed in the small intestine, which helps lower blood cholesterol levels. It is often combined with statins to further reduce cholesterol levels in hyperlipidemic patients.

API suppliers (15)

Suppliers of Ezetimibe backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• MSN Laboratories Private LimitedIndia3 active DMF
• APITORIA PHARMA PRIVATE LTDIndia2 active DMF
• Dr. Reddy's Laboratories Ltd.India2 active DMF
• SYMED LABS LTDIndia2 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China2 active DMF
• Lupin LimitedIndia2 active DMF
• Hetero Labs LimitedIndia1 active DMF
• MATRIX PHARMACORP PRIVATE LTD1 active DMF
• RAKS PHARMA PVT LTDIndia1 active DMF
• TAPI NL BV1 active DMF
• CHANGZHOU PHARMACEUTICAL FACTORYChina1 active DMF
• Neuland Laboratories LimitedIndia1 active DMF
• MATRIX PHARMACORP PRIVATE LTD1 active DMF
• SIGNA SA DE CV
• WATERSTONE PHARMACEUTICALS (HUBEI) CO LTD

Patent & exclusivity (US)

Per the FDA Orange Book (13 approved US products), the latest listed US patent on Ezetimibe expires 29 Apr 2026. Generic API sourcing typically opens up once these lapse.

Therapeutic areas